38.19
Collegium Pharmaceutical Inc (COLL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
5.76%
188.00
|
177.76 | 159.30 | 145.28 | 144.92 |
Cost Of Revenue |
1.02%
79.62
|
80.43 | 62.51 | 54.47 | 53.47 |
Gross Profit |
11.36%
108.38
|
97.32 | 96.79 | 90.81 | 91.46 |
Operating Expenses |
3.12%
73.28
|
75.64 | 61.95 | 43.34 | 41.98 |
Benefits Costs and Expenses |
2.10%
170.97
|
174.63 | 143.72 | 116.18 | 108.30 |
Costs And Expenses |
2.10%
170.97
|
174.63 | 143.72 | 116.18 | 108.30 |
Operating Income/Loss |
61.87%
35.10
|
21.69 | 34.84 | 47.47 | 49.47 |
Income/Loss From Continuing Operations Before Tax |
445.32%
17.02
|
3.122 | 15.58 | 29.10 | 36.62 |
Income Tax Expense/Benefit, Deferred |
440.63%
-2.914
|
-0.539 | -8.733 | -3.513 | -4.412 |
Income Tax Expense/Benefit |
615.18%
5.042
|
0.705 | 6.245 | 9.491 | 8.909 |
Income/Loss From Continuing Operations After Tax |
395.78%
11.98
|
2.417 | 9.335 | 19.61 | 27.71 |
|
395.78%
11.98
|
2.417 | 9.335 | 19.61 | 27.71 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.05%
31.81
|
31.79 | 32.26 | 32.43 | 32.33 |
Diluted Average Shares |
18.99%
39.08
|
32.84 | 40.16 | 40.38 | 41.44 |
Basic Earnings Per Share |
375.00%
0.38
|
0.08 | 0.29 | 0.60 | 0.86 |
Diluted Earnings Per Share |
385.71%
0.34
|
0.07 | 0.27 | 0.52 | 0.71 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):